Literature DB >> 32345850

Collateral damage of the COVID-19 outbreak: expression of concern.

Anne-Laure Feral-Pierssens1,2,3, Pierre-Géraud Claret4, Tahar Chouihed5,6.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32345850      PMCID: PMC7202126          DOI: 10.1097/MEJ.0000000000000717

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   4.106


× No keyword cloud information.
During the first wave of coronavirus disease 2019 (COVID-19) outbreak, several countries experienced the same phenomenon before being struck: a sudden calm, silence, few patients, quiet halls and less ambulances. Then, when the wave of patients with severe COVID began to strike, these usual emergency patients were still nowhere to be seen. In Europe, as in North America, emergency departments noticed a major decrease of daily visits since the beginning of the outbreak and the implementation of public health measures. The spectacular decrease seems to be a uniform view shared on social media by emergency physicians all around Europe and even overseas in Quebec. While the population abided by the containment measures and hospitals closed most of their elective activities to cope with the anticipated surge in intensive care needs, emergency departments self-emptied. Some patients may have opted for an alternative pathway for medical care while others may have forgone or postponed their urgent care. As Colineaux et al. [1] reported in a large sample of emergency department visits in France, 20% of adult patients were considered severely ill and required emergency care while 62% were intermediate cases who needed urgent care and technical resources. If some reasons for emergency department visits such as trauma have probably decreased due to the lockdown, there is no reason to think that the rate of stroke, myocardial infarction, appendicitis, or seizure have suddenly dropped during these peculiar weeks [2,3]. Based on electronic medical and administrative data systems of 22 hospitals of the eastern part of France, a region that has been struck early and with a high intensity of the COVID wave, we report a decrease of 26% of all emergency department visits, which comprises A DECREASE OF: 34% of strokes, 32% of transitory ischemic attacks, 64% of unstable angina, 42% of appendicitis, and 36% of seizures. In Honk Kong, Tam et al. [4] described the care management of a handful of patients with consecutive ST-elevation myocardial infarction (STEMI) after containment measures. When compared to 108 patients with STEMI taken care of in 2019, the authors report an increased delay between symptom onset and first medical contact in 2020. Authors raised concerns that patients may have been reluctant to consult in this particular context and rather postponed healthcare even though their life could be at stake. Emergency physicians should definitely be worried about this collateral damage that the COVID-19 outbreak is generating. Other countries that faced serious infectious disease outbreaks such as Ebola have reported major side effects, such as the diversion of needed care for other diseases and an increased mortality burden that was not attributed to Ebola itself but rather to a stressed and overwhelmed healthcare system [5]. Thus, poor outcomes and unexpected consequences are to be reported beyond the perimeter of the outbreak. In the COVID-19 context, there may be many reasons that explain why the usual emergency department patients seem to have disappeared despite the fact that all hospitals have managed to keep effective emergency pathways for non-COVID patients. Patients might have developed strategies different from the usual pathways and invested different healthcare resources such as teleconsultation or COVID-free walk-in clinics standing away from usual pathways. These new approaches and trajectories should be analyzed as potential substitutes for part of the usual emergency visits. However, it is unlikely that all the usual emergency department patients have benefitted from those alternatives especially patients with severe illnesses and those requiring emergency settings. Other suggestions are that patients might have fled emergency departments and waiting rooms because of the anxiety and fear of being infected by SARS_cov2 through patients’ or providers’ proximity. They might have restrained themselves from looking for any medical advice since all efforts of the healthcare system and public health authorities seem focused on COVID-19 management only. However, since unmet needs are associated with an increased risk of complications and worse outcomes [6,7], the quietness of our emergency departments should make us worry and should be considered as collateral damages that were not expected and anticipated during this outbreak and of the consequences of which will emerge in the coming weeks. That is why we urge emergency physicians and public health authorities to: Enjoin all patients to seek urgent care when needed and to avoid any delays. This should be expressed loudly and clearly while the outbreak is still ongoing. Patients need to be reassured and should know precisely that a specific COVID-free pathway has been planned in each facility with dedicated resources in order to avoid nosocomial infections. Engage in the assessment of all collateral damages that were not expected while organizing our departments to fight the outbreak. Efforts should be focused on understanding the reasons that led or compelled non-COVID patients to avoid or delay urgent care. This aspect of the crisis should not be neglected when the post-COVID outbreak report will be formulated. Find out and describe the new strategies that usual emergency department patients displayed during the outbreak in other settings away from the usual emergency pathways. In conclusion, we recommend that the huge efforts and research funding that are now focused on the improvement, management, and containment of the COVID-19 outbreak do not avoid describing and analyzing the medical collateral damages that are still in the shadows but will spread when the outbreak subsides.

Acknowledgements

The authors would like to thank the Est rescue Network (Celine Giget, Marc Noizet, MD, Bruno Maire, MD). A.-L.F.-P. and T.C. supervised data collection. A.-L.F.-P. drafted the manuscript. T.C. and P.G.C. contributed substantially to its revision.

Conflicts of interest

There are no conflicts of interest.
  7 in total

1.  Incidence, management and short-term prognosis of status epilepticus in the emergency department: a population survey.

Authors:  Peiman Nazerian; Delia Lazzeretti; Simone Vanni; Emilia Donnarumma; Simone Magazzini; Germana Ruggiano; Gianfranco Giannasi; Stefano Grifoni; Gaetano Zaccara
Journal:  Eur J Emerg Med       Date:  2019-06       Impact factor: 2.799

2.  Impact of the Ebola outbreak on health systems and population health in Sierra Leone.

Authors:  J W T Elston; A J Moosa; F Moses; G Walker; N Dotta; R J Waldman; J Wright
Journal:  J Public Health (Oxf)       Date:  2016-12-02       Impact factor: 2.341

3.  Why are people increasingly attending the emergency department? A study of the French healthcare system.

Authors:  Helene Colineaux; Fanny Pelissier; Laure Pourcel; Thierry Lang; Michelle Kelly-Irving; Olivier Azema; Sandrine Charpentier; Sebastien Lamy
Journal:  Emerg Med J       Date:  2019-07-16       Impact factor: 2.740

4.  Management of chest pain in the French emergency healthcare system: the prospective observational EPIDOULTHO study.

Authors:  Sandrine Charpentier; Sebastien Beaune; Luc Marie Joly; Abdo Khoury; François-Xavier Duchateau; Raphael Briot; Bertrand Renaud; François-Xavier Ageron
Journal:  Eur J Emerg Med       Date:  2018-12       Impact factor: 2.799

5.  Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis.

Authors:  Michele Heisler; Hwajung Choi; Allison B Rosen; Sandeep Vijan; Mohammed Kabeto; Kenneth M Langa; John D Piette
Journal:  Med Care       Date:  2010-02       Impact factor: 2.983

6.  High prevalence of forgoing healthcare for economic reasons in Switzerland: a population-based study in a region with universal health insurance coverage.

Authors:  I Guessous; J M Gaspoz; J M Theler; H Wolff
Journal:  Prev Med       Date:  2012-08-23       Impact factor: 4.018

7.  Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.

Authors:  Chor-Cheung Frankie Tam; Kent-Shek Cheung; Simon Lam; Anthony Wong; Arthur Yung; Michael Sze; Yui-Ming Lam; Carmen Chan; Tat-Chi Tsang; Matthew Tsui; Hung-Fat Tse; Chung-Wah Siu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-03-17
  7 in total
  20 in total

1.  Impact of COVID-19 on ischemic stroke care in Hungary.

Authors:  Péter Pál Böjti; Géza Szilágyi; Balázs Dobi; Rita Stang; István Szikora; Balázs Kis; Ákos Kornfeld; Csaba Óváry; Lóránd Erőss; Péter Banczerowski; Wojciech Kuczyński; Dániel Bereczki
Journal:  Geroscience       Date:  2021-08-18       Impact factor: 7.713

2.  Resuming Dental and Craniomaxillofacial Surgical Missions During the COVID-19 Pandemic: Guidelines and Recommendations.

Authors:  Victoria A Mañón; Ashley Tran; Ziad C Sifri; Shahid R Aziz
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2021-01-04

3.  Family Medicine Practice During COVID-19 Pandemic in Canton Sarajevo: Positive and Negative Aspects.

Authors:  Zaim Jatic; Natasa Trifunovic; Hasiba Erkocevic; Elvira Hasanovic; Katmerka Ceric; Baskim Bajrami; Maksida Jasarevic; Larisa Gavran; Amra Zalihic; Melida Hasanagic; Edin Dautbegovic; Senada Selmanovic; Samir Dedovic; Olivera Batic-Mujanovic
Journal:  Mater Sociomed       Date:  2022-03

4.  The impact of the COVID-19 pandemic on paediatric emergency service.

Authors:  İlknur Fidancı; Medine Ayşin Taşar; Bahar Akıntuğ; İzzet Fidancı; İsmail Bulut
Journal:  Int J Clin Pract       Date:  2021-06-05       Impact factor: 3.149

5.  Impact of the COVID-19 outbreak on neurological consultation in an emergency department.

Authors:  Milan Maretta; Matej Škorvánek; Veronika Jurková; Norbert Leško; Zuzana Gdovinová
Journal:  Acta Neurol Belg       Date:  2022-01-16       Impact factor: 2.396

6.  Impact of COVID-19 Pandemic on the Implantation of Intra-Cardiac Devices in Diabetic and Non-Diabetic Patients in the Western of Romania.

Authors:  Silvius Alexandru Pescariu; Cristina Tudoran; Gheorghe Nicusor Pop; Sorin Pescariu; Romulus Zorin Timar; Mariana Tudoran
Journal:  Medicina (Kaunas)       Date:  2021-05-03       Impact factor: 2.430

7.  Assessment of Referrals and Hospitalizations in the Hospital Transformed into COVID-19 Facility in Poland during the "Spring Wave" of the Epidemic in 2020-A Cross-Sectional Study.

Authors:  Agnieszka Kasiukiewicz; Zyta Beata Wojszel
Journal:  Int J Environ Res Public Health       Date:  2021-07-03       Impact factor: 3.390

8.  A snapshot of European neurosurgery December 2019 vs. March 2020: just before and during the Covid-19 pandemic.

Authors:  T Mathiesen; M Arraez; T Asser; N Balak; S Barazi; C Bernucci; C Bolger; M L D Broekman; A K Demetriades; Z Feldman; M M Fontanella; N Foroglou; J Lafuente; A D Maier; B Meyer; M Niemelä; P H Roche; F Sala; N Samprón; U Sandvik; K Schaller; C Thome; M Thys; M Tisell; P Vajkoczy; M Visocchi
Journal:  Acta Neurochir (Wien)       Date:  2020-07-08       Impact factor: 2.216

9.  COVID-19 related reduction in pediatric emergency healthcare utilization - a concerning trend.

Authors:  Christian Dopfer; Martin Wetzke; Anna Zychlinsky Scharff; Frank Mueller; Frank Dressler; Ulrich Baumann; Michael Sasse; Gesine Hansen; Alexandra Jablonka; Christine Happle
Journal:  BMC Pediatr       Date:  2020-09-07       Impact factor: 2.125

10.  How Can Health Systems Better Prepare for the Next Pandemic? Lessons Learned From the Management of COVID-19 in Quebec (Canada).

Authors:  Hassane Alami; Pascale Lehoux; Richard Fleet; Jean-Paul Fortin; Joanne Liu; Randa Attieh; Stéphanie Bernadette Mafalda Cadeddu; Mamane Abdoulaye Samri; Mathilde Savoldelli; Mohamed Ali Ag Ahmed
Journal:  Front Public Health       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.